Clinical trial
Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced…
NCT00002773 · St. Vincent Medical Center - Los Angeles, Other · Completed
Key facts
| NCT number | NCT00002773 |
|---|---|
| Title | Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer |
| Official title | A CLINICAL TRIAL FOR PANCREAS CANCER USING ACTIVE INTRALYMPHATIC IMMUNOTHERAPY WITH INTERFERON-TREATED PANCREAS CANCER TISSUE CULTURE CELLS, GMCSF, AND LOW-DOSE CYCLOPHOSPHAMIDE |
| Lead sponsor | St. Vincent Medical Center - Los Angeles, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug |
| Interventions | allogeneic tumor cell vaccine, recombinant interferon alfa, sargramostim, cyclophosphamide |
| Start date | May 1, 1996 |
| Completion | Apr 1, 2004 |
| First posted | Apr 29, 2004 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: